Artisan, Singapore’s A-Bio Join Forces On Recombinant Sepsis Candidate
This article was originally published in The Pink Sheet Daily
Executive Summary
Massachusetts firm is first-of-a-kind venture capital-funded, Japanese spinoff to focus on a top-priority compound, Artisan CEO tells “The Pink Sheet” DAILY.